Versant Capital Management »

Day One Biopharmaceuticals I shares owned by Versant Capital Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3k 604 7.05
2025-06-30 $3.9k 604 6.50

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Deerfield Management Company
Franklin Resources
Rubric Capital Management
State Street Corporation
Vestal Point Capital
Pictet Asset Management Holding SA
Alyeska Investment Group
Braidwell
Geode Capital Management
AIGH Capital Management
MAK Capital One

View all funds holding Day One Biopharmaceuticals I